CURADIS GMBH has a total of 22 patent applications. Its first patent ever was published in 2000. It filed its patents most often in EPO (European Patent Office), Australia and Hungary. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are FABRE KRAMER PHARMACEUTICALS I, NOBERA PHARMA SL and PANAPHIX INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 7 | |
#2 | Australia | 3 | |
#3 | Hungary | 3 | |
#4 | Canada | 2 | |
#5 | United States | 2 | |
#6 | WIPO (World Intellectual Property Organization) | 2 | |
#7 | China | 1 | |
#8 | Republic of Korea | 1 | |
#9 | Serbia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Steroids | |
#4 | Specific use of cosmetics |
# | Name | Total Patents |
---|---|---|
#1 | Unteregger Gerhard | 12 |
#2 | Windisch Martin | 6 |
#3 | Wieland Heinrich | 2 |
#4 | Schönfeld Wolfgang | 2 |
#5 | Teichmann Alexander Tobias | 2 |
#6 | Schmidt Alfred | 2 |
#7 | Schonfeld Wolfgang | 1 |
Publication | Filing date | Title |
---|---|---|
EP3632445A1 | Combinations with a c-19 steroid for treating cancers | |
RS56621B1 | C-19 steroids for inhibiting neovascularization | |
EP2500062A2 | C-19 steroids for specific therapeutic uses | |
AU2007251822A1 | Use of 4, 17 beta-dihydroxyandrost-4-ene-3-one for treating cancers | |
US2006178353A1 | Medicament for preventing and/or treating mammary carcinoma, containing a steroidal aromatase inhibitor |